Age-related cognitive decline and associations with sex, education and apolipoprotein E genotype across ethnocultural groups and geographic regions: a collaborative cohort study

The prevalence of dementia varies around the world, potentially contributed to by international differences in rates of age-related cognitive decline. Our primary goal was to investigate how rates of age-related decline in cognitive test performance varied among international cohort studies of cogni...

Full description

Saved in:
Bibliographic Details
Published inPLoS medicine Vol. 14; no. 3; p. e1002261
Main Authors Lipnicki, Darren M., Crawford, John D., Dutta, Rajib, Thalamuthu, Anbupalam, Kochan, Nicole A., Andrews, Gavin, Lima-Costa, M. Fernanda, Castro-Costa, Erico, Brayne, Carol, Matthews, Fiona E., Stephan, Blossom C. M., Lipton, Richard B., Katz, Mindy J., Ritchie, Karen, Scali, Jacqueline, Ancelin, Marie-Laure, Scarmeas, Nikolaos, Yannakoulia, Mary, Dardiotis, Efthimios, Lam, Linda C. W., Wong, Candy H. Y., Fung, Ada W. T., Guaita, Antonio, Vaccaro, Roberta, Davin, Annalisa, Kim, Ki Woong, Han, Ji Won, Kim, Tae Hui, Anstey, Kaarin J., Cherbuin, Nicolas, Butterworth, Peter, Scazufca, Marcia, Kumagai, Shuzo, Chen, Sanmei, Narazaki, Kenji, Ng, Tze Pin, Gao, Qi, Reppermund, Simone, Brodaty, Henry, Lobo, Antonio, Lopez-Anton, Raúl, Santabárbara, Javier, Sachdev, Perminder S.
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 21.03.2017
Public Library of Science (PLoS)
Subjects
Online AccessGet full text
ISSN1549-1676
1549-1277
1549-1676
DOI10.1371/journal.pmed.1002261

Cover

More Information
Summary:The prevalence of dementia varies around the world, potentially contributed to by international differences in rates of age-related cognitive decline. Our primary goal was to investigate how rates of age-related decline in cognitive test performance varied among international cohort studies of cognitive aging. We also determined the extent to which sex, educational attainment, and apolipoprotein E ε4 allele (APOE*4) carrier status were associated with decline. We harmonized longitudinal data for 14 cohorts from 12 countries (Australia, Brazil, France, Greece, Hong Kong, Italy, Japan, Singapore, Spain, South Korea, United Kingdom, United States), for a total of 42,170 individuals aged 54-105 y (42% male), including 3.3% with dementia at baseline. The studies began between 1989 and 2011, with all but three ongoing, and each had 2-16 assessment waves (median = 3) and a follow-up duration of 2-15 y. We analyzed standardized Mini-Mental State Examination (MMSE) and memory, processing speed, language, and executive functioning test scores using linear mixed models, adjusted for sex and education, and meta-analytic techniques. Performance on all cognitive measures declined with age, with the most rapid rate of change pooled across cohorts a moderate -0.26 standard deviations per decade (SD/decade) (95% confidence interval [CI] [-0.35, -0.16], p < 0.001) for processing speed. Rates of decline accelerated slightly with age, with executive functioning showing the largest additional rate of decline with every further decade of age (-0.07 SD/decade, 95% CI [-0.10, -0.03], p = 0.002). There was a considerable degree of heterogeneity in the associations across cohorts, including a slightly faster decline (p = 0.021) on the MMSE for Asians (-0.20 SD/decade, 95% CI [-0.28, -0.12], p < 0.001) than for whites (-0.09 SD/decade, 95% CI [-0.16, -0.02], p = 0.009). Males declined on the MMSE at a slightly slower rate than females (difference = 0.023 SD/decade, 95% CI [0.011, 0.035], p < 0.001), and every additional year of education was associated with a rate of decline slightly slower for the MMSE (0.004 SD/decade less, 95% CI [0.002, 0.006], p = 0.001), but slightly faster for language (-0.007 SD/decade more, 95% CI [-0.011, -0.003], p = 0.001). APOE*4 carriers declined slightly more rapidly than non-carriers on most cognitive measures, with processing speed showing the greatest difference (-0.08 SD/decade, 95% CI [-0.15, -0.01], p = 0.019). The same overall pattern of results was found when analyses were repeated with baseline dementia cases excluded. We used only one test to represent cognitive domains, and though a prototypical one, we nevertheless urge caution in generalizing the results to domains rather than viewing them as test-specific associations. This study lacked cohorts from Africa, India, and mainland China. Cognitive performance declined with age, and more rapidly with increasing age, across samples from diverse ethnocultural groups and geographical regions. Associations varied across cohorts, suggesting that different rates of cognitive decline might contribute to the global variation in dementia prevalence. However, the many similarities and consistent associations with education and APOE genotype indicate a need to explore how international differences in associations with other risk factors such as genetics, cardiovascular health, and lifestyle are involved. Future studies should attempt to use multiple tests for each cognitive domain and feature populations from ethnocultural groups and geographical regions for which we lacked data.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMCID: PMC5360220
Conceptualization: PSS DML JDC NAK SK CB FEM BCMS CHYW LCWL MFLC ECC KJA AL NS ED MY RBL MJK GA KWK MS.Data curation: DML JDC RD AT AWTF NC SK SC KN TPN QG CHYW LCWL JSc CB FEM BCMS THK MFLC ECC KJA RLA JSa MJK JWH KWK PB MS.Formal analysis: RD AT SC NAK CHYW LCWL MFLC ECC RLA JSa NS MY JWH KWK MS FEM BCMS.Funding acquisition: PSS.Investigation: AWTF NC SK SC KN TPN QG CHYW LCWL AG RV AD MLA HB THK NAK MFLC ECC KJA AL RLA JSa NS ED MY KR RBL MJK SR JWH GA KWK PB MS CB FEM BCMS.Methodology: JDC AT SK SC KN TPN QG CB FEM LCWL KJA NS ED MY KWK MS.Project administration: DML.Software: JSa MJK KWK MS FEM BCMS.Supervision: PSS.Validation: CB FEM BCMS LCWL JSc MLA MFLC ECC KJA AL RLA JSa RBL MJK JWH KWK MS.Visualization: AT.Writing – original draft: DML JDC PSS.Writing – review & editing: DML PSS JDC RD AT NAK GA MFLC ECC CB FEM BCMS RBL MJK KR JSc MLA NS MY ED LCWL CHYW AWTF AG RV AD KWK JWH THK KJA NC PB MS KS CS KN TPN QG SR HB AL RLA JSa.
Membership of the Cohort Studies of Memory in an International Consortium (COSMIC) is provided in the Acknowledgments.
I have read the journal's policy and the authors of this manuscript have the following competing interests: JDC is supported by the National Health and Medical Research Council of Australia (NHMRC Program Grant ID 568969). CB is a member of the Editorial Board of PLOS Medicine. FEM is a member of the Editorial Board of PLOS Medicine. RBL is the Edwin S. Lowe Professor of Neurology at the Albert Einstein College of Medicine in New York and receives research support from the NIH; receives support from the Migraine Research Foundation and the National Headache Foundation and serves on the editorial board of Neurology and as senior advisor to Headache; has reviewed for the NIA and NINDS, holds stock options in eNeura Therapeutics; serves as consultant, advisory board member, or has received honoraria from American Academy of Neurology, Alder, Allergan, American Headache Society, Amgen, Autonomic Technologies, Avanir, Biohaven, Biovision, Boston Scientific, Colucid, Dr. Reddy’s, Electrocore, Eli Lilly, eNeura Therapeutics, GlaxoSmithKlein (formerly Novartis), Merck, Pernix, Pfizer, Supernus, Teva, Trigemina, Vector, Vedanta; and receives royalties from Wolff’s Headache, 8th Edition, Oxford Press University, 2009, Wiley and Informa. MJK is funded by NIH/NIA and the following private foundations: Czap Foundation, Sylvia and Leonard Marx Foundation and also receives consultation fees from Eli Lilly and Company. HB has received departmental grants for drug trials from Lilly, Merck, Sanofi, Servier and Tau Therapeutics; is on the advisory board for Nutricia and has been asked to be an advisor to Lundbeck, Otuska and Eli Lilly; and is on clinical advisory committees for Montefiore Homes and Cranbrook Care, both of which operate residential/ long-term care homes. AL has received honoraria or travel fees from Lundbeck and Sanofi. PSS would like to acknowledge financial support from the National Health & Medical Research Council (APP1093083), the Vincent Fairfax Foundation and the Yulgilbar Foundation for COSMIC. All other authors declare no competing interests.
ISSN:1549-1676
1549-1277
1549-1676
DOI:10.1371/journal.pmed.1002261